Skip to content
Clinical Trials – home

Dalecarlia Clinical research center

Verified siteinfo

Sweden Torggatan 18, 795 30 Rättvik, Sweden

  • Chronic kidney disease · Hypertension · Type 2 diabetes mellitus
  • Adult patients

About Specializations

Dalecarlia Clinical research center in Rättvik, Sweden specialises in clinical trials of conditions such as Chronic kidney disease, Hypertension, Type 2 diabetes mellitus, and other specialisations. This site conducts important research.

Main research areas of the site

Nephrology and Hypertension

The medical center is at the forefront of research in nephrology and hypertension, focusing on innovative treatments for chronic kidney disease (CKD) and high blood pressure. The center's work is pivotal in understanding the progression of CKD and developing therapies that can effectively manage and slow its advancement.

  • Chronic Kidney Disease Management
  • Hypertension Treatment
  • Renal Function Preservation

Through cutting-edge clinical trials, the center contributes significantly to the development of new therapeutic strategies that aim to improve patient outcomes and quality of life for those suffering from kidney-related conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Torggatan 18795 30 RättvikSweden
Recruiting now
no trials
Conditions studied
3
Partner status
Verified site

More sites in RättvikSweden

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

3 clinical trials

Study on the Effects of Zibotentan and Dapagliflozin in Patients with Chronic Kidney Disease and High Protein Levels

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:AstraZeneca AB

Chronic kidney disease+1

Not recruiting

Study on Baxdrostat and Dapagliflozin for Adults with Chronic Kidney Disease and High Blood Pressure

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB

Evaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Dulaglutide
  • Sponsor:Eli Lilly & Co.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.